Introduction of everolimus in kidney transplant recipients at a late posttransplant stage
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Transplantation
Reference39 articles.
1. Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era
2. Chronic allograft nephropathy
3. Calcineurin Inhibitor Nephrotoxicity
4. Immunosuppressive Drugs in Kidney Transplantation
5. Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases;Cell & Bioscience;2022-01-03
2. Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study;Frontiers in Public Health;2021-03-31
3. Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan;Clinical and Experimental Nephrology;2021-02-11
4. An open-label randomized clinical trial to evaluate the efficacy of everolimus versus tacrolimus in triple maintenance immunosuppressive therapy for kidney transplant patients;Brazilian Journal of Medical and Biological Research;2021
5. The rapamycin analog Everolimus reversibly impairs male germ cell differentiation and fertility in the mouse†;Biology of Reproduction;2020-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3